OM:BIOG BBiotechs
A Look At BioGaia (OM:BIOG B) Valuation After Expanded Ewopharma Distribution Deal
BioGaia (OM:BIOG B) has renewed and widened its distribution agreement with Ewopharma, now covering more than 15 European countries. This move puts fresh attention on how its probiotics reach key markets.
See our latest analysis for BioGaia.
At a share price of SEK111.7, BioGaia has seen short term momentum pick up, with a 4.1% 1 day and 10.7% 90 day share price return, even though the 1 year total shareholder return shows a 4% decline and the 5 year total shareholder return of 57.7% points...